Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria (PAFCUTIII)

This study has been completed.
Sponsor:
Collaborator:
Hospital del Mar
Information provided by (Responsible Party):
Marina Abajian, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01605487
First received: May 11, 2012
Last updated: October 14, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)